• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Lazard Declares Quarterly Dividend of $0.50 Per Share

    4/24/25 4:15:00 PM ET
    $LAZ
    Investment Managers
    Finance
    Get the next $LAZ alert in real time by email

    Lazard, Inc. (NYSE:LAZ) today announced that its Board of Directors has voted to declare a quarterly dividend of $0.50 per share on its outstanding common stock. The dividend is payable on May 16, 2025, to stockholders of record on May 5, 2025.

    About Lazard

    Founded in 1848, Lazard is the preeminent financial advisory and asset management firm, with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. For more information, please visit Lazard.com and follow Lazard on LinkedIn.

    LAZ-CPE

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250424685518/en/

    Media Relations

    Shannon Houston, +1 212-632-6880

    [email protected]

    Jessica Francisco, +1 212-632-6571

    [email protected]

    Investor Relations

    Alexandra Deignan, +1 212-632-6886

    [email protected]

    Get the next $LAZ alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LAZ

    DatePrice TargetRatingAnalyst
    4/7/2025$56.00 → $33.00Equal-Weight → Underweight
    Morgan Stanley
    1/3/2025Outperform → Peer Perform
    Wolfe Research
    12/20/2024$65.00 → $57.00Outperform → Mkt Perform
    Keefe Bruyette
    12/9/2024$60.00 → $63.00Overweight → Equal-Weight
    Morgan Stanley
    9/12/2024$51.00Equal Weight
    Wells Fargo
    1/29/2024$51.00Outperform
    Keefe Bruyette
    1/3/2024$42.00Peer Perform → Outperform
    Wolfe Research
    9/19/2023$37.00 → $32.00Neutral → Sell
    Goldman
    More analyst ratings

    $LAZ
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in May

      Lazard Global Total Return and Income Fund, Inc. (the "Fund") (NYSE:LGI) is confirming today, pursuant to its Managed Distribution Policy, as previously authorized by its Board of Directors, a monthly distribution of $0.14646 per share on the Fund's outstanding common stock. The distribution is payable on July 22, 2025 to shareholders of record on July 10, 2025. The ex-dividend date is July 10, 2025. The Fund will pay a previously declared distribution today, June 24, 2025. The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid, including today's distribution, from the following sources: net investment income, net realized ca

      6/24/25 5:12:00 PM ET
      $LAZ
      $LGI
      Investment Managers
      Finance
    • Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer

      Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, announces the appointment of Ajay Dhankhar, PhD, as Chief Corporate Development & Strategy Officer, effective today. Ajay will report to Chief Executive Officer Deepak Nath and join the Smith+Nephew Executive Committee.  As both a senior management consultant and investment banker, Ajay has advised CEOs and Boards at some of the world's leading healthcare companies, helping deliver substantial shareholder value.  Ajay's experience includes 25 years with McKinsey & Company where he was a Senior Partner and held multiple leadership roles including Global Head of Strategy across all industries, Global Head of Strategy

      6/23/25 8:00:00 AM ET
      $LAZ
      $SNN
      Investment Managers
      Finance
      Industrial Specialties
      Health Care
    • Lazard Releases 2025 Levelized Cost of Energy+ Report

      Renewables Remain Competitive, as Utility-Scale Solar and Onshore Wind Remain Most Cost-Effective Forms of New-Build Energy Generation The Tightening of Capacity Markets Has Led to a Resurgence in New-Build Gas Generation Projects, Despite Higher Levelized Costs of Energy and Commodity Price Exposure Lazard Inc. (NYSE:LAZ) is proud to announce the release of the 18th edition of its Levelized Cost of Energy+ (LCOE+) report, a widely-cited, annual analysis that provides insights into the cost competitiveness of various energy generation technologies. The report explores key aspects of energy generation, energy storage, and system-level considerations while reflecting on developments over

      6/16/25 7:00:00 AM ET
      $LAZ
      Investment Managers
      Finance

    $LAZ
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by Lazard Inc.

      SCHEDULE 13G - Lazard, Inc. (0001311370) (Subject)

      5/14/25 10:45:27 AM ET
      $LAZ
      Investment Managers
      Finance
    • Lazard Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Lazard, Inc. (0001311370) (Filer)

      5/13/25 5:28:18 PM ET
      $LAZ
      Investment Managers
      Finance
    • Amendment: SEC Form SCHEDULE 13G/A filed by Lazard Inc.

      SCHEDULE 13G/A - Lazard, Inc. (0001311370) (Subject)

      5/12/25 10:36:17 AM ET
      $LAZ
      Investment Managers
      Finance